Teleconference - DTx US commercialization plan
02 July 2020
| Date | 02.07.2020 |
| Time | 1:30 pm CET. The presentation will be held by Nikolaj Sørensen, CEO and President, and Dennis Urbaniak, EVP Digital Therapeutics |
| ir@orexo.com | Questions can also be sent in advance to ir@orexo.com, no later than 11.00 am CET |
| Phone number to participate in the Audiocast & Q&A | SE: +46 8 566 42 707 UK: +44 33 330 09 271 US: +1 83 382 305 86 (no code needed) |
| Internet link | https://tv.streamfabriken.com/2020-07-02-orexo-pressconference |
| Presentation material | The presentation can be downloaded from the company´s website approximately one hours ahead of the presentation at, https://orexo.com/investors/reports-presentations-and-audiocasts/ |
| For more information please contact | Lena Wange, IR and Communications Director Tel: +46 18 780 88 00 E-mail: ir@orexo.com |